| DRAVP ID | Name | Sequence | Target Organism | Pubmed/Patent ID | 
|---|---|---|---|---|
| DRAVPe01393 | UL54(1221-1242) | LPRRLHLEPAFLPYSVKAHECC | HCMV | 12857903 | 
| DRAVPe01394 | UL54(1206-1225) | PGGETARKDKFLHMVLPRRL | HCMV | 12857903 | 
| DRAVPe01395 | UL54(1191-1210) | EQVLKAVTNVLSPVFPGGET | HCMV | 12857903 | 
| DRAVPe01396 | UL54(1176-1195) | YVREHGVPIHADKYFEQVLK | HCMV | 12857903 | 
| DRAVPe01397 | UL54(1161-1180) | PPSAVCNYEVAEDPSYVREH | HCMV | 12857903 | 
| DRAVPe01398 | UL54(1223-1242) | RRLHLEPAFLPYSVKAHECC | HCMV | 12857903 | 
| DRAVPe01399 | UL54(1221-1241) | LPRRLHLEPAFLPYSVKAHEC | HCMV | 12857903 | 
| DRAVPe01400 | UL54(1221-1240) | LPRRLHLEPAFLPYSVKAHE | HCMV | 12857903 | 
| DRAVPe01468 | A4 | SSCNMGWDTPACCVWFPYWV | HCMV | 19740994 | 
| DRAVPe01469 | A8 | MAVGLVLCDWWLGEYLLEA | HCMV | 19740994 | 
| DRAVPe01470 | A56 | PVLQPALSLSCGPEPLLLSC | HCMV | 19740994 | 
| DRAVPe01471 | A110 | IEVTFVNRRGDGAELWYLSA | HCMV | 19740994 | 
| DRAVPe01653 | Peptide 2 | GGVLVQPG | SARS-CoV-2,HCMV,VZV | 34502335 | 
| DRAVPe01654 | Peptide 3 | GGVLVQPG | SARS-CoV-2,HCMV,VZV | 34502335 | 
| DRAVPe01655 | Peptide 4 | GGVLVQPG | SARS-CoV-2,HCMV,VZV | 34502335 | 
| DRAVPe01656 | Peptide 5 | GVLVQ | SARS-CoV-2,HCMV,VZV | 34502335 | 
| DRAVPe01657 | Peptide 6 | GVLV | SARS-CoV-2,HCMV,VZV | 34502335 | 
| DRAVPe02120 | HD-5(1–9) | ATCYCRTGR | HCMV | 32209394 | 
| DRAVPe02663 | - | RRRRR | HCMV | 10958789 | 
| DRAVPe02701 | SB101 | QKKIRVRLSA | HCMV | 20083141 | 
| DRAVPe02702 | SB102 | QKKIRVRL | HCMV | 20083141 | 
| DRAVPe02703 | SB103 | QKKIRVRWSA | HCMV | 20083141 | 
| DRAVPe02704 | SB104 | NKKIRVRL | HCMV | 20083141 | 
| DRAVPe02705 | SB105 | ASLRVRIKKQ | HCMV,MCMV | 20083141 | 
| DRAVPe02706 | SB105_A10 | ASLRVRIKK | HCMV,MCMV | 20083141 | 
| DRAVPe02707 | SB106 | FKKIRVRL | HCMV | 20083141 | 
| DRAVPe02708 | SB107 | QKKIRVRISA | HCMV | 20083141 | 
| DRAVPe02709 | SB108 | QKKIRVRLSW | HCMV | 20083141 | 
| DRAVPe02710 | SB109 | QKKIRVRFSA | HCMV | 20083141 | 
| DRAVPe02711 | SB110 | QKKIRFRLSA | HCMV | 20083141 |